Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences: Paul Clancy

Exact Sciences has appointed Paul Clancy as a Class I member of its board. In connection with his appointment, Clancy was also named to the board's audit and finance committee.

Clancy has more than 30 years of experience in financial management and strategic business planning, and served as the executive vice president and CFO of Alexion Pharmaceuticals from July 2017 to November 2019. Prior to joining Alexion, he served in several positions at Biogen, including executive VP of finance and CFO. Before Biogen, Clancy spent 13 years serving in a variety of financial and general management positions at PepsiCo. 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.